Key result
Severity guides conservative or surgical management for Ebstein's anomaly linked to MYH7 and NKX2.5 mutations.
Provides an overview of the genetic basis and stage-specific surgical management strategies for Ebstein's anomaly.
Answers are grounded in this paper and cite their sources.
Supports individualized planning in Ebstein's anomaly; extends prior reviews but leaves open prospective validation of strategies.
Ebstein's anomaly is uncommon. Genetic bases of this congenital heart defect may be related to the mutations in myosin heavy chain 7 and NKX2.5, among others. Asymptomatic patients with Ebstein's anomaly can be conservatively treated and kept under close follow-up, whereas surgical operation is indicated for those patients with evidence of right heart dilation and progressively impaired ventricular systolic function. A biventricular repair consisting of the reconstruction of a competent monocuspid tricuspid valve, right ventriculorrhaphy, subtotal atrial septal defect closure, and aggressive reduction atrioplasty is suitable for most patients, and 1.5-ventricular repair (bidirectional Glenn shunt) is indicated for patients with poor right ventricular function; by contrast, heart transplantation is used in patients with severe left ventricular dysfunction.
No takes yet. Share an insight, caveat, or question.
Shi‐Min Yuan (2016) conducted a review in Ebstein's anomaly. Ebstein's anomaly is an uncommon congenital heart defect with genetic bases including mutations in myosin heavy chain 7 and NKX2.5, managed conservatively or surgically depending on severity.
Synapse has enriched 10 related papers. Consider them for comparative context: